X Bioscience PCL (BKK:XBIO)
Thailand · Delayed Price · Currency is THB 0.0800
0.00 (0.00%)
At close: Aug 10, 2026
X Bioscience PCL Financials Overview
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 159.29 | 129.65 | 319.24 | 311.77 | 344.49 | 254.04 |
Revenue Growth | -46.33% | -59.39% | 2.40% | -9.50% | 35.60% | -38.88% |
Gross Profit Gross Profit Growth | 64.2 | 53.04 | 138.61 | 152.11 | 172.18 | 127.23 |
Operating Income Operating Income Growth | -433.66 | -454.31 | -251.21 | -120.43 | -283.23 | -100.56 |
Net Income Net Income Growth | -742.29 | -468.87 | -260.22 | -147.52 | -575.99 | -276.45 |
Earnings Per Share EPS Growth | -0.06 | -1.17 | -1.41 | -1.18 | -4.95 | -2.38 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Selling Food and Beverages Selling Food and Beverages Growth | 102.57 | 135.54 | 323.6 | 314.48 | 344.49 | 254.04 |
Eliminated Transaction Eliminated Transaction Growth | - | -5.99 | -4.36 | -2.7 | - | - |
Total Total Growth | 159.18 | 129.55 | 319.24 | 311.77 | 344.49 | 254.04 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 28.08 | 4.66 | 47.96 | 26.75 | 16.16 | 28.01 |
Total Debt Total Debt Growth | 178.18 | 240.36 | 354.56 | 415.04 | 472.98 | 469.05 |
Net Cash (Debt) Net Cash Growth | -150.11 | -235.69 | -306.6 | -388.29 | -456.82 | -441.04 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.01 | -0.59 | -1.67 | -3.10 | -3.93 | -3.79 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -107.31 | -75.29 | -18.51 | -76.31 | -152.41 | -139.13 |
Capital Expenditures CapEx Growth | -8.71 | -3.59 | -36.33 | -57.28 | -138.81 | -73.43 |
Free Cash Flow Free Cash Flow Growth | -116.02 | -78.88 | -54.84 | -133.59 | -291.22 | -212.57 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 40.31% | 40.91% | 43.42% | 48.79% | 49.98% | 50.08% |
Operating Margin | -272.25% | -350.40% | -78.69% | -38.63% | -82.22% | -39.58% |
Pretax Margin | -470.23% | -351.50% | -87.05% | -47.68% | -97.66% | -41.55% |
Profit Margin | -466.01% | -361.63% | -81.51% | -47.32% | -167.20% | -108.82% |
FCF Margin | -72.84% | -60.84% | -17.18% | -42.85% | -84.54% | -83.67% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 6.10 | 1.38 | 3.23 | 2.35 | 4.68 | 13.91 |